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Abstract 
 
Magnetic nanoparticles encapsulated in Methyl methacrylate (Eudragit L-
100) microspheres containing Indomethacin drug were prepared and their 
detailed structural and magnetic characteristics were studied. Iron oxide 
nanoparticles were obtained by chemical coprecipitation of Fe(II) and 
Fe(III) salts and stabilized with tetra-methyl ammonium hydroxide. 
Microspheres were prepared by solvent evaporation technique. We 
characterized the magnetic microspheres in terms of morphology, 
composite microstructure, size and size distribution, magnetic properties 
and in-vitro release patterns. The microspheres were uniform both in shape 
and usually also in size; their size distribution was narrow. All the 
magnetic parameters confirm superparamagnetic nature of the 
microspheres with magnetizations up to 20–30 emu/g of microspheres. The 
in-vitro release profile was studied in pH 7.4 phosphate buffer medium up 
to 8 hours using USP XXII dissolution apparatus. Drug release in the first 
hour was found to increase and reached a maximum, releasing 
approximately 60-85% of the total drug content from the microspheres 
within 8 hours. From this study, it could be suggested that magnetic 
Methyl methacrylate microspheres could be retained at their target site in-
vivo and such microspheres can be used in biomedical applications and 
research areas such as target drug delivery, selective blood detoxification, 
tissue engineering and replacement, and magnetic resonance imaging 
(MRI) contrast agents. 
 
Keywords: Methyl methacrylate, Magnetite, Indomethacin, single 
emulsion solvent evaporation Technique, Chemical co-precipitation 
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Introduction 
In recent years, polymeric controlled drug 
delivery systems have evolved as one of the most 
attractive   areas   in   drug   delivery   and   drug  
 
 
 
targeting. The drug release is controlled by the 
properties of the polymer-drug systems and to 
some extent environmental factors such as pH, 
enzymes and inter-patient variance [1-2].  
Despite several advantages offered by controlled 
drug release, a major problem associated with all doi:10.5138/ ijdd.2010.0975.0215.03059 
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these systems so far developed give release rates 
that are either constant or decrease with time, but 
not augmented delivery on demand[3]. It can be 
achieved with the systems, which are associated 
with external or feed back control such as 
magnetic control[4]. Magnetically targeted drug 
delivery system (MT-DDS) will be a promising 
way, which involves binding a drug to a small 
biocompatible magnetically active component, 
entrapped in the biodegradable polymeric matrix 
and formulating in to a pharmacologically active 
stable formulation, which is injected into the 
blood stream and using a high-gradient magnetic 
field to pull them out of suspension in the target 
region[5-7]. Magnetic microspheres will be 
formulated with an intension to produce a depot 
near the target organ, by placing a suitable 
magnet near it. From the depot, drug will be 
released slowly & carried to the target organ 
through blood[8-10]. By localizing the drug carrier 
near the target organ, unwanted distribution of 
drug to non target organ can be avoided. This 
approach will localize the drug only at target site 
& minimize the drug-induced toxicity[11]. 
Recently, biodegradable magnetic carriers have 
attracted increasing interest in biomedical and 
clinical research[12-14]. For example, magnetic 
resonance imaging (MRI) contrasts agents[15]. 
The success of these technologies depends 
largely on the synthesis of magnetic spheres from 
biocompatible, non-toxic polymers such as 
Methyl methacrylate (Eudragit L-100) and ethyl 
cellulose[16-19]. For applications requiring invivo 
magnetic targeting, for example, magnetic drug 
delivery, the magnetic carriers must have a 
proper size range (i.e. between 200 nm and 3 
mm) and high magnetizations to enable 
technically feasible external magnetic guidance 
within the vasculature. In these applications the 
microspheres (i.e. 1–2 mm) would be more 
advantageous than nanospheres in terms of better 
targeting and easier capture [20-24]. To do this, one 
of the main challenges has been the fabrication of 
magnetic spheres with high magnetizations, good 
drug encapsulation efficiency and high drug 
payload [25-26]. This generally requires that the 
magnetic carriers are biodegradable, smaller than 
red blood cells (i.e. 7–8 mm), have a proper size 
range, and contain high concentrations of the 
magnetic material. However, the hydrophilic 
surface properties of magnetite compounds make 
it challenging to attain high magnetite content in 
hydrophobic biodegradable polymers such as 
Eudragit (L-100) [27]. The usual method of 
encapsulating hydrophilic magnetite can be done 
by single emulsion solvent evaporation protocol 
to prepare biodegradable/biocompatible magnetic 
microspheres that are 1–2 mm in mean diameter 
and contain a large concentration of magnetic 
material by encapsulating a hydrophobic 
magnetite material [28]. Magnetic carrier 
technology would benefit from this simplified 
procedure and can be utilized in biomedical 
applications and research areas such as target 
drug delivery, selective blood detoxification, 
tissue engineering and replacement, and magnetic 
resonance imaging (MRI) contrast agents [29-30]. 
Indomethacin (IND) is a non-steroidal anti-
inflammatory drug (NSAID) that reduces fever, 
pain, and inflammation [12]. IND was selected 
mainly because of its side effects such as stomach 
irritation or intestinal bleeding or ulcers and can 
increase blood pressure and decrease kidney 
function, it is important to decrease used dosages 
and side effects during the treatment. One of the 
possibilities to do it is direct delivery of the drug 
to the target area of the body by external 
magnetic field. 
The aim of the present study was to prepare and 
characterize Eudragit magnetic microspheres 
loaded with Indomethacin. This study illustrates 
preparation of size controlled magnetic 
microspheres with high magnetization of the 
prepared microspheres by emulsion solvent 
evaporation technique. The prepared 
microspheres were then studied for their 
morphology,  magnetic property, and drug release 
characteristics. 
 
Materials and Method 
 
Materials 
Methyl methacrylate (Eudragit L-100) (Sigma-
aldrich, USA), Ferrous sulphate and Ferric 
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chloride (Hi-Pure, Fine chem. Industries, 
Chennai), Indomethacin (Nu Therapeutics Pvt 
Ltd, Hyderabad), Tetra-methyl Ammonium 
hydroxide (SD fine chemicals), all other 
chemicals and solvents used are of analytical 
grade. 
  
Methods 
Preparation of magnetite nano particles  
Magnetite nano particles were prepared by 
chemical co-precipitation method which in 
involves co-precipitation of ferrous and ferric 
forms in 1:2 ratio in alkaline medium. In brief, 
6N NaOH was added to 100ml of a solution 
containing iron (Fe) in the ratio of 1:2 (Fe2+: 
Fe3+). The resulting mixture was allowed to 
digest for 30min at 60oC to give colloidal 
magnetite suspension. 6g of oleic acid was then 
mixed with 9.6ml of 3N NaOH solution and 50ml 
of distilled water, the mixture was heated to 
60oC. Following the dissolution of sodium oleate, 
the solution was added to the magnetite 
suspension and stirred for 30min at 90oC. After 
cooling, the pH was slightly acidified with 1N 
HCl solution, resulting in the flocculated 
suspension which was filtered and stored until 
use [3]. 
 
Preparation  of  eudragit  magnetic 
microspheres 
Microspheres were prepared by solvent 
evaporation technique with necessary 
modifications. Accurately weighed but varying 
amounts of Eudragit E-100 was dissolved in 10 
ml of acetone over a cyclo-mixer, and accurately 
weighed drug was added in the polymer solution. 
50 mg of magnesium stearate was then added to 
the solution of polymer and drug in acetone. 
Finally specified amount of magnetite was added 
to the drug-polymer solution. The organic phase 
was poured drop-wise to 25 ml of 1:1 mixture of 
light and heavy liquid paraffin with vigorous 
stirring over a mechanical stirrer. High stirring 
rates of approximately 4,000 rpm were employed 
to obtain microspheres of smaller size. Stirring 
was continued for eight hours. 20 ml of hexane 
was added to the stirred contents. The batch was 
filtered and washed thrice with hexane, 10 ml 
each, to remove any adhering liquid paraffin from 
the surface of microspheres. Then, several 
washings with distilled water were given to 
remove any un-entrapped drug on the surface of 
the microspheres. Several batches of 
microspheres were prepared by varying drug-
polymer ratio, keeping all other formulation 
factors constant [11].  
 
Characterization 
 
Scanning Electron Microscopy 
The magnetic microspheres characterized in 
terms of morphology, composite microstructure, 
size and size distribution using scanning electron 
microscopy (SEM, S-500, and HITACHI). Prior 
to observation, samples were mounted on metal 
grids, using double-sided adhesive tape and 
coated by gold under vacuum and were scanned 
at an accelerating voltage of 15kV before 
observation.  
 
Magnetic properties of the microspheres 
A vibrating sample magnetometer (VSM, Lake 
Shore Cryotronics Inc., OH) was employed to 
measure the magnetizations of starting magnetite 
and microspheres at room temperature. The 
samples were dried in a vacuum overnight by 
lypholizer.  Several parameters like, saturated 
induced magnetization, magnetic susceptibility 
and hysteresis loops were measured. All the 
quantities were measured in the same sample. 
 
X-ray diffraction studies 
The physical nature of the drug entrapped in the 
magnetic microspheres was further confirmed by 
diffraction patterns obtained from X-ray 
diffraction studies using X-ray diffractometer 
(XD-D1, Shimadzu, Japan), in the range 5–70◦ of 
2θ. The working conditions were CuK radiation, 
30 kV, 20mA and with a slit of 1.1–0.3 mm.  
 
In vitro release studies 
Drug release tests were performed according to 
USP XXIV paddle method for each size fraction 
separately. Accurately weighed amounts (100mg) 
of microspheres were introduced into 900ml of 
PBS (phosphate buffer saline, pH 7.4) and stirred 
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with 100 rpm at 37 + 0.5°C. Five milliliters 
samples were withdrawn and filtered at selected 
time intervals. The concentration of 
Indomethacin was determined 
spectrophotometrically at 318 nm [2]. 
 
Result and Discussion 
The magnetic microspheres were spherical in 
geometry [Figure 1]. The surface was primarily 
smooth, although some roughness could be 
identified in certain areas of some spheres. 
Magnetite appears to be encapsulated 
heterogeneously within the microspheres. All 
samples are in the size range between 300 and 2.5 
mm in diameter with a broad size distribution. 
The poly-dispersity index (PI) of 0.2, indicating a 
particle size distribution (PSD) characteristic of a 
sample with broad size range, is in agreement 
with microscopy.  
 
Figure 1: SEM of Eudragit (L-100) magnetic 
microspheres loaded with Indomethacin 
 
Saturation magnetization (Ms) of Eudragit 
microspheres was determined from the hysteresis 
loops after subtraction of paramagnetic 
component using linear interpolation in the upper 
30% of the field range [Figure 2]. This value 
(determined from the loops measured at room 
temperature) can be used to approximate the 
content of iron oxides in the microspheres (as of 
Fe3O4).  The values of the induced 
magnetization measured at 7 T and 5K and their 
ratios to those obtained at 300K were in the range 
of 23.8 for smaller microspheres and 13.5 for 
larger microspheres. This ratio can be interpreted 
in terms of (super) paramagnetic contribution due 
to the energy of thermal vibrations. It is clear that 
while smaller microspheres show high (super) 
paramagnetic contributions, the largest 
microspheres exhibit the lowest magnetization 
ratios. 
 
 Figure 2: Vibrating sample magnetometer 
(VSM) of synthesized magnetic composite 
microspheres measured at 300 K. 
 
Magnetic susceptibility (both in-phase and out-
of-phase AC components) were measured by 
applying the AC field 4Oe (320 A/m) at 
frequencies 0.1, 1, 10, 100, 500 and 1000 Hz. 
Typical superparamagnetic behavior is evident 
from the hyperbolic decay of susceptibility from 
the curve, following the Curie–Weiss 
paramagnetic law. Microsphere show typical 
superparamagnetic pattern of the in-phase FDS, 
with maximum around 75–80 K, followed by 
hyperbolic decay. Therefore, despite the absence 
of blocking temperature in the thermal 
demagnetization of FC and ZFC remanences, this 
observation can be considered as an indicator of 
the transition from true superparamagnetic 
behavior to ferrimagnetic one at lower 
temperatures. However, interpretation of these 
features requires further study. 
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The X-ray diffraction patterns of the magnetic 
nanoparticles and magnetic microspheres are 
shown in [Figure 3]. All XRD peaks could be 
attributed to the characteristic peaks of iron oxide 
spinel structure (Fe3O4). The peak broadening 
(311) indicated that the average crystallite size of 
the fabricated particles was only a few 
nanometers. Characteristic peaks of magnetite in 
magnetic microspheres confirmed the presence of 
magnetite particles in the prepared microspheres. 
It can be observed that the X-ray diffraction 
patterns of drug containing microspheres showed 
sharp peaks due to crystalline nature of the drug.  
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[Figure 4] shows the release profile of 
Indomethacin from magnetic Eudragit 
microspheres (1:1, 1:2, 1:3) until 8 h after 
dispersion in pH 7.4 buffer solution. As evident 
from the graph, the curve of dissolution release 
profile indicates that, with the increase in the 
polymer ratio release of Indomethacin from the 
microspheres decreases.  The concentration of the 
drug released from the microspheres increased 
and reached a maximum as the time proceeds 
until 6hrs and attains a steady state for the next 
two hours. The initial burst release could be  
 
 
 
 
Figure 3: X-ay diffraction patterns of magnetite nano-particle and formulation of Eudragit magnetic 
microspheres containing magnetite. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Release of Indomethacin from 
magnetic Eudragit microspheres up to 8h after 
dispersion () 1:1, () 1:2, (S) 1:3 of drug to 
polymer ratio 
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related to the surfacial drug as well as small size 
of the microspheres with increased surface area. 
The maximum concentration of Indomethacin 
released was 23.6µg/ml there by the maximum 
quantity of drug released after 8 h will be 82.4%. 
 
 
Conclusion 
Magnetic nanoparticles encapsulated in Methyl 
methacrylate (Eudragit L-100) microspheres 
containing Indomethacin drug were prepared and 
their detailed structural and magnetic 
characteristics were studied. Iron oxide 
nanoparticles were obtained by chemical 
coprecipitation method. Microspheres were 
prepared by solvent evaporation technique and 
were characterized  in terms of morphology, 
composite microstructure, size and size 
distribution using SEM, magnetic properties by 
VSM and in-vitro release patterns. All the 
magnetic parameters confirm superparamagnetic 
nature of the microspheres with magnetizations 
up to 20–30 emu/g of microspheres. 
Characteristic sharp peaks of magnetite in 
magnetic microspheres confirmed the presence of 
magnetite particles in the prepared microspheres 
and the drug was in crystalline form. The in-vitro 
release profile was studied in pH 7.4 phosphate 
buffer medium up to 8 hours using USP XXII 
dissolution apparatus. Drug release in the first 
hour was found to increase and reached a 
maximum, releasing approximately 60-85% of 
the total drug content from the microspheres 
within 8 hours. From this study, it could be 
suggested that magnetic Eudragit microspheres 
could be prepared using simple technique and 
such microspheres can be used in biomedical 
applications and research areas such as target 
drug delivery, selective blood detoxification, 
tissue engineering and replacement, and magnetic 
resonance imaging contrast agents. 
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